Kewaunee Scientific Reports Mixed FY26: Revenue Up 17% to $282M, EPS Falls 16% to $3.22
KEQU is trading near its 52-week low of $33.273 (7.7% above the low) on elevated volume (2.7× avg).
Summary
Kewaunee Scientific reported fiscal year 2026 results with revenue increasing 17.3% to $282 million, largely driven by the Nu Aire acquisition. However, net income declined 9.7% to $10.47 million and diluted EPS fell 15.9% to $3.22. This summary follows the official 10-K filing on the same day and preliminary results released via PR Newswire and an 8-K on June 23rd. The mixed results, with strong top-line growth but declining profitability and a reduced order backlog, present a nuanced picture for investors.
At the time of this announcement, KEQU was trading at $35.82 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $102.7M. The 52-week trading range was $33.27 to $60.89. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.